Data consistently shows that exercise is key to well-being in nearly every facet of life; its positive impact is unquestioned. But what about when people, perhaps not by choice, need to sit on the sidelines for a while?
Nov 12, 2021
0
50
When Vertex Pharmaceuticals announced last month that its investigational stem-cell-derived replacement therapy was, in conjunction with immunosuppressive therapy, helping the first patient in a Phase 1/2 clinical trial robustly ...
Nov 11, 2021
0
3
In these times of virtual meet-ups, negative news overload and widespread uncertainty, it's fair to say it has been a tough time for our brains. If you've been feeling mentally subpar, you may be floating around the edges ...
Nov 11, 2021
0
3
The therapeutic benefit to patients receiving mesenchymal stromal cell (MSC) therapy is not because the injected cells remain viable, but because of cell death, researchers at the Monash Biomedicine Discovery Institute (BDI) ...
Nov 11, 2021
0
29
A comprehensive study—conducted by researchers at Sanford Burnham Prebys, the National Cancer Institute (NCI) and other groups—has shown that gene editing, specifically gene knockout (KO), with CRISPR -Cas9 can favor ...
Nov 11, 2021
0
53
Combination treatment with immune checkpoint inhibitors nivolumab and ipilimumab demonstrates overall survival for patients with melanoma that has spread to the brain, according to Phase II study results published today in ...
Nov 11, 2021
0
11
Cognitive behavioral therapy (CBT) is one of the most common types of talk therapy in the United States. There are 11 criteria that cognitive behavioral therapists-in-training are normally judged on. What if their skills ...
Nov 10, 2021
0
45
Each year, one million Americans undergo percutaneous coronary intervention after a heart attack, or to alleviate symptoms of chest pressure. Current American Heart Association guidelines recommend that patients who undergo ...
Nov 10, 2021
0
36
Researchers have made a huge leap forward in finding a targeted therapy for acute myeloid leukemia.
Nov 10, 2021
0
110
Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients who are trial eligible despite no survival benefit, according to a new study by researchers ...
Nov 09, 2021
0
67
